Kodi-M Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.04%

Kodi-M Co Ltd (224060) has an Asset Resilience Ratio of 0.04% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 224060 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩33.00 Million
≈ $22.36K USD Cash + Short-term Investments

Total Assets

₩79.64 Billion
≈ $53.97 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Kodi-M Co Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Kodi-M Co Ltd to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Kodi-M Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 224060 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩33.00 Million 0.04%
Total Liquid Assets ₩33.00 Million 0.04%

Asset Resilience Insights

  • Limited Liquidity: Kodi-M Co Ltd maintains only 0.04% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Kodi-M Co Ltd Industry Peers by Asset Resilience Ratio

Compare Kodi-M Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
3Peak Inc
SHG:688536
Semiconductor Equipment & Materials 35.99%
Thinkon Semiconductor Jinzhou Corp
SHG:688233
Semiconductor Equipment & Materials 18.85%
JHT Design Co. Ltd. Cl A
SHG:603061
Semiconductor Equipment & Materials 9.01%
GIGAVIS LTD (PROPOSED)
KQ:420770
Semiconductor Equipment & Materials 28.97%
JiLin Sino-Microelectronics Co Ltd
SHG:600360
Semiconductor Equipment & Materials 8.45%
Semco Technologies Sas
PA:ALSEM
Semiconductor Equipment & Materials 0.08%
New Power Plasma Co.Ltd
KQ:144960
Semiconductor Equipment & Materials 0.99%
BCnC Co. Ltd.
KQ:146320
Semiconductor Equipment & Materials 1.60%

Annual Asset Resilience Ratio for Kodi-M Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Kodi-M Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.03% ₩24.00 Million
≈ $16.26K
₩72.31 Billion
≈ $49.00 Million
-11.41pp
2024-12-31 11.44% ₩10.76 Billion
≈ $7.29 Million
₩94.05 Billion
≈ $63.74 Million
-2.83pp
2023-12-31 14.28% ₩14.19 Billion
≈ $9.62 Million
₩99.39 Billion
≈ $67.36 Million
-11.36pp
2022-12-31 25.64% ₩24.00 Billion
≈ $16.27 Million
₩93.64 Billion
≈ $63.46 Million
+16.33pp
2021-12-31 9.30% ₩11.40 Billion
≈ $7.72 Million
₩122.49 Billion
≈ $83.01 Million
+3.50pp
2020-12-31 5.80% ₩7.25 Billion
≈ $4.91 Million
₩125.03 Billion
≈ $84.73 Million
-0.58pp
2019-12-31 6.38% ₩7.46 Billion
≈ $5.06 Million
₩117.03 Billion
≈ $79.31 Million
-13.78pp
2018-12-31 20.16% ₩18.93 Billion
≈ $12.83 Million
₩93.91 Billion
≈ $63.64 Million
-2.50pp
2017-12-31 22.66% ₩13.81 Billion
≈ $9.36 Million
₩60.95 Billion
≈ $41.31 Million
+5.95pp
2016-12-31 16.71% ₩11.39 Billion
≈ $7.72 Million
₩68.18 Billion
≈ $46.21 Million
--
pp = percentage points

About Kodi-M Co Ltd

KQ:224060 Korea Semiconductor Equipment & Materials
Market Cap
$14.56 Million
₩21.48 Billion KRW
Market Cap Rank
#26090 Global
#1910 in Korea
Share Price
₩4185.00
Change (1 day)
-12.72%
52-Week Range
₩2430.00 - ₩7110.00
All Time High
₩360000.00
About

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and chang… Read more